Max Robotics — Global Service Robot Directory + US Certification

About

Andrew Trainer is a leading urologic surgeon and researcher whose work has fundamentally advanced the treatment of benign prostatic hyperplasia (BPH), particularly for patients with large prostates. His primary research focus is the clinical application and validation of Aquablation, a minimally invasive, robotically-guided waterjet therapy for BPH. Trainer’s major contributions include demonstrating the safety and efficacy of this novel technology in the most challenging patient populations. His landmark 2019 study, cited 63 times, established the 1-year outcomes of Aquablation for men with prostates between 80-150 cc, a group often considered poor candidates for traditional surgery. He further solidified this evidence with 2-year follow-up data, proving the durability of symptom relief. Notably, his 2018 blinded randomized trial, with 42 citations, provided critical subgroup analysis showing that Aquablation offers superior preservation of ejaculatory function compared to standard transurethral resection of the prostate (TURP). Through these rigorous, high-impact studies, Trainer has positioned Aquablation as a game-changing alternative for men with large prostates, offering effective symptom relief while significantly reducing the risk of sexual side effects.